SutroVax reels in $85 mln Series C

Foster City, California-based SutroVax, a biopharmaceutical company, has secured $85 million in Series C financing. TPG Growth led the round with participation from other investors that included Medicxi, Foresite Capital, Abingworth, Longitude Capital, Frazier Health Care Partners, Pivotal bioVenture Partners, Roche Venture Fund and CTI Life Sciences Fund.

Source: Press Release